As Lisbon recovers from the 15,000 scientists and healthcare professionals descending onto its streets for the EASD, you might have caught our updates on science that made the headlines and the talk of the town: genetics. So for the final EASD installment, I’m bringing you some of my personal highlights… Is it still all about…
Genetics was high on the agenda at this year’s EASD, with a move toward challenging the ‘one-size-fits-all’ approach of diagnosing and treating different types of diabetes. Using genetics to prevent Type 1 TrialNet screens relatives of people with Type 1 diabetes to work out their personal risk of developing the condition. They have now screened…
The European Association for the Study of Diabetes (EASD) annual conference just drew to a close, and I’m bringing you the latest. Here’s the first EASD blog, summing up the stories you might have seen in the newspapers and what they actually mean. In sickness and in health Researchers in Denmark have suggested that your…
In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on pharmacists, superbugs, epidemics, prescriptions, activity and psychological support. The pharmacist will see you now… NHS England is continuing to build on its programme of pharmacists working alongside GPs…
In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on research. Treatment delays A new study has looked at ‘therapeutic inertia’ to try and estimate the size and cause of the problem in Type 2 diabetes (T2D). Therapeutic…
In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on technologies, medicines and treatments. Big and bigger data Sugar.IQ is the first app to come out of a collaboration between Medtronic and IBM’s Watson supercomputer and it gives…